Close Menu

360Dx

The researchers found that the reliable sampling of rare circulating tumor DNA fragments served as the key challenge for developing liquid biopsy assays.

The test measures changes in white blood cell size, distribution, cell counts, and deformability to determine the state of a patient's immune system.